N-Acetyl Semax Amidate

Approval status

We found no regulator that has approved it, and no published studies of this exact form. Its parent, Semax, is not approved by the FDA or EMA; in 2026 the FDA reviewed Semax (not this form) and found too little evidence of benefit or safety.³⁴

What it’s used or studied for

• Animal & lab only

  In a lab study, N-acetyl Semax (acetylated, but without the amide end) did not protect nerve-like cells from copper damage, while plain Semax did.²

• No studies

  Sold as a longer-lasting or stronger version of Semax. No published study has tested this.

• No studies

  Claims about memory, focus or stroke recovery come from studies of Semax itself, mostly small Russian studies, not from studies of this modified form.³

Each label shows how strong the evidence is: an approved use, human studies, animal or lab studies only, or a popular claim with no published studies. Being studied is not the same as being proven safe or effective.

Side effects

There are no human data on this modified form. For the parent, Semax, the FDA found very little safety information.³

Cautions

• Chemical changes can change how a peptide behaves, as the copper study showed. Effects and safety of Semax cannot be assumed to carry over.²
• For the parent, Semax, the FDA flagged a possible bleeding risk and concerns about impurities and immune reactions.³